These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 16226288)
1. Apparent elimination of EIAV ancestral species in a long-term inapparent carrier. Craigo JK; Sturgeon TJ; Cook SJ; Issel CJ; Leroux C; Montelaro RC Virology; 2006 Jan; 344(2):340-53. PubMed ID: 16226288 [TBL] [Abstract][Full Text] [Related]
2. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine. Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668 [TBL] [Abstract][Full Text] [Related]
4. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo. Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113 [TBL] [Abstract][Full Text] [Related]
5. Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease. Sponseller BA; Sparks WO; Wannemuehler Y; Li Y; Antons AK; Oaks JL; Carpenter S Virology; 2007 Jun; 363(1):156-65. PubMed ID: 17328936 [TBL] [Abstract][Full Text] [Related]
6. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses. McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012 [TBL] [Abstract][Full Text] [Related]
7. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony. Belshan M; Baccam P; Oaks JL; Sponseller BA; Murphy SC; Cornette J; Carpenter S Virology; 2001 Jan; 279(1):185-200. PubMed ID: 11145901 [TBL] [Abstract][Full Text] [Related]
8. Hyperglobulinemia and lymphocyte subset changes in naturally infected, inapparent carriers of equine infectious anemia virus. Russell KE; Walker KM; Miller RT; Sellon DC Am J Vet Res; 1998 Aug; 59(8):1009-15. PubMed ID: 9706205 [TBL] [Abstract][Full Text] [Related]
16. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain. Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667 [TBL] [Abstract][Full Text] [Related]
17. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. Leroux C; Issel CJ; Montelaro RC J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627 [TBL] [Abstract][Full Text] [Related]
18. Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection. Mealey RH; Leib SR; Pownder SL; McGuire TC J Virol; 2004 Sep; 78(17):9295-305. PubMed ID: 15308724 [TBL] [Abstract][Full Text] [Related]
19. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus. Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982 [TBL] [Abstract][Full Text] [Related]
20. Gag genetic heterogeneity of equine infectious anemia virus (EIAV) in naturally infected horses in Canada. Nagarajan MM; Simard C Virus Res; 2007 Nov; 129(2):228-35. PubMed ID: 17767972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]